Cytek Biosciences Executive and Leadership Team

Wenbin Jiang, the Chief Executive Officer & Chairman at Cytek Biosciences, directs the company's overarching strategy and corporate governance. Jiang guides the organization's vision, ensuring alignment with its mission to develop advanced cell analysis tools. This leadership role involves setting strategic priorities for research and development, particularly concerning the patented Full Spectrum Profiling technology. Jiang oversees the company's expansion into new markets and the enhancement of its product portfolio, which includes the Aurora and Northern Lights systems. The Chief Executive Officer & Chairman also manages relationships with key stakeholders and drives the company's growth trajectory. By focusing on innovation and market leadership, Wenbin Jiang ensures Cytek Biosciences remains at the forefront of the biotechnology sector, providing high-resolution and high-sensitivity cell analysis solutions to research institutions worldwide.

William McCombe, the Chief Financial Officer at Cytek Biosciences, manages all financial operations and fiscal strategy. McCombe oversees budgeting, financial planning, and reporting, ensuring the company's financial health and stability. This role is critical for supporting Cytek's research and development initiatives, including the advancement of its patented Full Spectrum Profiling technology. The Chief Financial Officer directs capital allocation, manages investor relations, and ensures compliance with financial regulations across global offices in North America, Europe, and Asia. McCombe's financial oversight enables the continued development and distribution of scientific instruments like the Aurora and Northern Lights systems. By optimizing financial performance, William McCombe directly supports the company's mission to provide cutting-edge cell analysis solutions to scientific research institutions and laboratories.

Ming Yan, the Chief Technology Officer at Cytek Biosciences, spearheads the company's technological innovation and product development. Yan directs the research and development efforts focused on advancing the patented Full Spectrum Profiling technology, which is central to Cytek's advanced cell analysis tools. This leadership position involves overseeing the engineering and scientific teams responsible for creating high-resolution and high-sensitivity cell analysis instruments, such as the Aurora and Northern Lights systems. The Chief Technology Officer ensures that the company's technological roadmap aligns with market needs and scientific advancements. Yan's expertise drives the continuous improvement of reagents and supporting software, enhancing the capabilities of Cytek's offerings for research institutions. Through strategic technological direction, Ming Yan ensures Cytek Biosciences maintains its competitive edge in the biotechnology sector.

Connie Wedel, the Chief People Officer at Cytek Biosciences, leads all human resources functions and talent management strategies. Wedel is responsible for cultivating a robust organizational culture that supports innovation and scientific advancement, particularly in the development of advanced cell analysis tools. This role involves overseeing recruitment, employee development, and retention initiatives across Cytek's global operations in North America, Europe, and Asia. The Chief People Officer ensures that the company attracts and retains top scientific and technical talent necessary for advancing patented technologies like Full Spectrum Profiling. Wedel also manages employee relations and ensures compliance with labor laws, fostering a productive work environment. By prioritizing people operations, Connie Wedel directly contributes to the company's capacity to deliver cutting-edge scientific instruments and solutions.

Valerie Barnett, the Chief Legal Officer at Cytek Biosciences, oversees all legal affairs and ensures regulatory compliance. Barnett manages intellectual property strategy, safeguarding the company's patented Full Spectrum Profiling technology and other innovations. This critical role involves advising on legal matters related to product development, global operations, and business transactions, including the distribution of scientific instruments like the Aurora and Northern Lights systems. The Chief Legal Officer ensures adherence to legal frameworks in North America, Europe, and Asia, supporting the company's expansion into clinical applications in China and the EU. Barnett also manages corporate governance and risk mitigation, protecting Cytek Biosciences' interests. Through diligent legal counsel, Valerie Barnett supports the company's mission to provide advanced cell analysis solutions to research institutions worldwide.